Microsoft says hackers from Russia, North Korea attacked COVID-19 vaccine makers

Seven leading pharma firms and vaccine researchers in Canada, France, India, South Korea and the United States were targeted in the attack.

Published - November 16, 2020 01:53 pm IST

Microsoft says hackers from Russia, North Korea attacked COVID-19 vaccine makers.

Microsoft says hackers from Russia, North Korea attacked COVID-19 vaccine makers.

(Subscribe to our Today's Cache newsletter for a quick snapshot of top 5 tech stories. Click here to subscribe for free.)

Microsoft on Friday said cyberattacks originating in Russia and North Korea targeted pharmaceutical companies developing COVID-19 vaccine.

Seven leading pharma firms and vaccine researchers in Canada, France, India, South Korea and the United States were targeted in the attack.

Most of these firms are at various stages of clinical trials. One is involved in trials, and another has developed COVID-19 test. Other targeted organisations have contracts with or investments from government agencies for COVID-19 related work.

Microsoft has blocked a majority of these attacks, but some were successful, and the tech giant has notified all targeted organisations.

Microsoft has blamed attacks on three hacker groups: Strontium, an actor originating from Russia; and two actors from North Korea called Zinc and Cerium.

Strontium is said to have used password spray and brute force login attempts to steal credentials.

Zinc and Cerium both use spear phishing method to lure users into sharing their credentials.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.